	california biotech cbio sees st qtr loss california biotechnology inc said it expects to report a loss of dlrs to dlrs for the first quarter due to increased investment in research and manufacturing and a scaleup of production the company said research spending is running to pct above a year ago as it tries to commercialize its products as quickly as possible and increased expenditures are expected to continue for several more quarters it said operating results will fluctuate quarter to quarter depending on the timing of significant payments from commercial partners in the first three months of the company lost dlrs the company changed its fiscal year in to a calendar year from a year ending november for the first quarter of last year ended february california biotech ed dlrs reuter 
